NYSE ARCA | ETF
The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index.
It will normally invest at least 80% of its net assets in securities that comprise the underlying index.
The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of theU. S.
Food and Drug Administration clinical trials.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 5.51% |
CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 5.36% |
VRNA | Verona Pharma PLC ADR | Healthcare | Biotechnology | 4.73% |
RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 4.38% |
AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 4.24% |
CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 4.07% |
ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.97% |
SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 3.93% |
VKTX | Viking Therapeutics Inc | Healthcare | Biotechnology | 3.74% |
KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 3.59% |
PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 3.50% |
RYTM | Rhythm Pharmaceuticals Inc | Healthcare | Biotechnology | 3.47% |
RNA | Avidity Biosciences Inc | Healthcare | Biotechnology | 3.26% |
ZLAB | Zai Lab Ltd | Healthcare | Biotechnology | 3.15% |
ACLX | Arcellx Inc | Healthcare | Biotechnology | 3.08% |
IMVT | Immunovant Inc | Healthcare | Biotechnology | 2.89% |
AKRO | Akero Therapeutics Inc | Healthcare | Biotechnology | 2.83% |
MRUS | Merus BV | Healthcare | Biotechnology | 2.79% |
ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 2.73% |
PTGX | Protagonist Therapeutics Inc | Healthcare | Biotechnology | 2.67% |